Description
Developer of a minimally-invasive system for monitoring tissue perfusion. The company helps in easing critical assessment of critically-ill patients in intensive care units
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Mar-2018 | Completed | Out of Business | |||
1. Angel (individual) | 16-Dec-2009 | Completed | Startup |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-2408364-A1 | Systems and method for characteristic parameter estimation of gastric impedance spectra in humans | Inactive | 16-Mar-2009 | 000000000 | |
EP-2408364-A4 | Systems and method for characteristic parameter estimation of gastric impedance spectra in humans | Inactive | 16-Mar-2009 | 000000000 | |
JP-2012520739-A | System and method for characteristic parameter evaluation of human stomach impedance spectrum | Pending | 16-Mar-2009 | 000000000 | |
US-6970738-B1 | Complex impedance spectrometer using parallel demodulation and digital conversion | Active | 04-Feb-2002 | 000000000 | 00 |
EP-1174080-B1 | Catheter for use in a system for monitoring mucosal damage in hollow viscous organs | Inactive | 19-Jul-2000 | A61B5/05 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Jerry Gibson | President & Chief Executive Officer |